These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35039873)

  • 21. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review.
    Bendstrup N; Hejl AM; Salvesen L
    J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow.
    Fukui Y; Hishikawa N; Sato K; Yunoki T; Kono S; Matsuzono K; Nakano Y; Ohta Y; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2015 Oct; 357(1-2):178-82. PubMed ID: 26227830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
    Morishima R; Bandoh M; Sunami Y; Isozaki E
    Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A
    J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways.
    Jang Y; Thuraisamy T; Redding-Ochoa J; Pletnikova O; Troncoso JC; Rosenthal LS; Dawson TM; Pantelyat AY; Na CH
    Clin Transl Med; 2022 Nov; 12(11):e1076. PubMed ID: 36354133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging in progressive supranuclear palsy.
    Stamelou M; Knake S; Oertel WH; Höglinger GU
    J Neurol; 2011 Apr; 258(4):549-58. PubMed ID: 21181185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.
    Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K
    J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration of neural thread protein in cerebrospinal fluid from progressive supranuclear palsy and Parkinson's disease.
    Yamada T; Chong JK; Asahina M; Koguchi Y; Hirayama K
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):631-5. PubMed ID: 8301879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy.
    Pezzella FR; Paglia MG; Colosimo C
    Mov Disord; 2004 Feb; 19(2):220-2. PubMed ID: 14978681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L; Brew B; Sutton I; Tisch S
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
    Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
    Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progressive supranuclear palsy].
    Nakamura T; Imai H
    Nihon Rinsho; 1997 Jan; 55(1):127-30. PubMed ID: 9014435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
    Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini MG; Padovani A; Di Luca M
    Neurobiol Aging; 2009 Jan; 30(1):34-40. PubMed ID: 17709155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.